Ligand Binding Mechanism in Steroid Receptors: From Conserved Plasticity to Differential Evolutionary Constraints.

[1]  S. Geschwindner,et al.  Drug discovery at the single molecule level: inhibition-in-solution assay of membrane-reconstituted β-secretase using single-molecule imaging. , 2015, Analytical chemistry.

[2]  M. Baker,et al.  Detection and functional portrayal of a novel class of dihydrotestosterone derived selective progesterone receptor modulators (SPRM) , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  Martin Kotev,et al.  Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniques. , 2015, Biophysical journal.

[4]  V. Guallar,et al.  Monte Carlo Free Ligand Diffusion with Markov State Model Analysis and Absolute Binding Free Energy Calculations. , 2014, Journal of chemical theory and computation.

[5]  Adam J Pawson,et al.  The Concise Guide to Pharmacology 2013/14: Nuclear Hormone Receptors , 2013, British journal of pharmacology.

[6]  F. Jaisser,et al.  Mineralocorticoid receptor and cardiac arrhythmia , 2013, Clinical and experimental pharmacology & physiology.

[7]  Shigeru Shibata,et al.  Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia. , 2013, Cell metabolism.

[8]  J. Changeux.  50 years of allosteric interactions: the twists and turns of the models , 2013, Nature Reviews Molecular Cell Biology.

[9]  L. Martínez,et al.  Dynamics of nuclear receptor Helix-12 switch of transcription activation by modeling time-resolved fluorescence anisotropy decays. , 2013, Biophysical journal.

[10]  Adam Godzik,et al.  Divergent evolution of protein conformational dynamics in dihydrofolate reductase , 2013, Nature Structural &Molecular Biology.

[11]  A. Capelli,et al.  Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor. , 2013, Journal of Medicinal Chemistry.

[12]  T. Ratajczak,et al.  The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones. , 2013, Molecular endocrinology.

[13]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[14]  Evgeny M. Zdobnov,et al.  OrthoDB: a hierarchical catalog of animal, fungal and bacterial orthologs , 2012, Nucleic Acids Res..

[15]  E. Ortlund,et al.  Deciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid Receptors , 2012, The Journal of Biological Chemistry.

[16]  D. Moras,et al.  Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors , 2012, Proceedings of the National Academy of Sciences.

[17]  Victor Guallar,et al.  Exploration of Protein Conformational Change with PELE and Meta-Dynamics. , 2012, Journal of chemical theory and computation.

[18]  M. J. Chalmers,et al.  Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. , 2012, Structure.

[19]  Hideki Matsui,et al.  Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists. , 2011, Journal of medicinal chemistry.

[20]  Norbert Garnier,et al.  Ligand entry pathways in the ligand binding domain of PPARγ receptor , 2011, FEBS letters.

[21]  Albert C. Pan,et al.  Pathway and mechanism of drug binding to G-protein-coupled receptors , 2011, Proceedings of the National Academy of Sciences.

[22]  G. de Fabritiis,et al.  Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations , 2011, Proceedings of the National Academy of Sciences.

[23]  F. Jaisser,et al.  Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. , 2011, Kidney international.

[24]  R. Sitruk-Ware,et al.  The use of newer progestins for contraception. , 2010, Contraception.

[25]  R. Fletterick,et al.  Hormone Binding and Co-regulator Binding to the Glucocorticoid Receptor are Allosterically Coupled , 2010, The Journal of Biological Chemistry.

[26]  E. Ortlund,et al.  An epistatic ratchet constrains the direction of glucocorticoid receptor evolution , 2009, Nature.

[27]  Vincent Le Guilloux,et al.  Fpocket: An open source platform for ligand pocket detection , 2009, BMC Bioinformatics.

[28]  Leandro Martínez,et al.  Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations. , 2008, Molecular endocrinology.

[29]  J. W. Becker,et al.  Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation , 2008, Proceedings of the National Academy of Sciences.

[30]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[31]  D. Picard,et al.  The glucocorticoid responses are shaped by molecular chaperones , 2007, Molecular and Cellular Endocrinology.

[32]  E. Ortlund,et al.  Crystal Structure of an Ancient Protein: Evolution by Conformational Epistasis , 2007, Science.

[33]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[34]  Andrzej Joachimiak,et al.  Structural plasticity in the oestrogen receptor ligand‐binding domain , 2007, EMBO reports.

[35]  K. Yamamoto,et al.  A conformational switch in the ligand-binding domain regulates the dependence of the glucocorticoid receptor on Hsp90. , 2007, Journal of molecular biology.

[36]  B. Darimont,et al.  Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain , 2006, Proceedings of the National Academy of Sciences.

[37]  Victor Guallar,et al.  PELE:  Protein Energy Landscape Exploration. A Novel Monte Carlo Based Technique. , 2005, Journal of chemical theory and computation.

[38]  H. Xu,et al.  Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. , 2005, Molecular cell.

[39]  Claudine Mayer,et al.  Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension , 2005, Nature Structural &Molecular Biology.

[40]  Jan Löwe,et al.  Structural insights into FtsZ protofilament formation , 2004, Nature Structural &Molecular Biology.

[41]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[42]  T. Willson,et al.  Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition , 2002, Cell.

[43]  P. Yen,et al.  Physiological and molecular basis of thyroid hormone action. , 2001, Physiological reviews.

[44]  Peter Scholz,et al.  Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor , 2000, The Journal of Biological Chemistry.

[45]  H. Akil,et al.  A Conserved Proline in the hsp90 Binding Region of the Glucocorticoid Receptor Is Required for hsp90 Heterocomplex Stabilization and Receptor Signaling* , 1998, The Journal of Biological Chemistry.

[46]  H. Gronemeyer,et al.  The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.

[47]  P. Sigler,et al.  Atomic structure of progesterone complexed with its receptor , 1998, Nature.

[48]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[49]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[50]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[51]  F. Holsboer,et al.  Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. , 1993, European journal of pharmacology.

[52]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[53]  Structural bioinformatics Advance Access publication April 5, 2011 ProDy: Protein Dynamics Inferred from Theory and Experiments , 2010 .

[54]  T. Cole.  Glucocorticoid action and the development of selective glucocorticoid receptor ligands. , 2006, Biotechnology annual review.

[55]  M. Gouy,et al.  WWW-query: an on-line retrieval system for biological sequence banks. , 1996, Biochimie.

[56]  R. Houze,et al.  References and Notes Supporting Online Material Evolution of Hormone-receptor Complexity by Molecular Exploitation , 2022 .